Chapter 10: Patient-Centric AR for Interactive Training and Medication Adherence
Synopsis
Author
Zulekha Mohammad,
Department of Pharmacy Practice, Sir C.R. Reddy College of Pharmaceutical Sciences, Andhra Pradesh, India
Abstract
Medication non-adherence and device handling errors represent significant drivers of preventable therapeutic failures, clinical hospitalizations, and elevated healthcare expenditures. Conventional paper patient package inserts exacerbate this problem through microscopic typography, complex medical jargon, and poor physical accessibility. Augmented Reality modernizes consumer drug education by transforming physical packaging into dynamic, interactive digital health portals. By scanning packaging cartons via consumer smartphones or smart eyewear, patients access personalized, multi-layered visual guides: animated 3D mechanisms of action, interactive adverse event navigators, and multi-lingual voiceover instructions driven by GS1 Digital Link cloud routing. For complex mechanical delivery devices—such as Metered-Dose Inhalers, Dry Powder Inhalers, autoinjector pens, and pre-filled syringes—vision-guided 3D tutorials deconstruct multi-step administration protocols. The system tracks device tilt, provides real-time breathing pacing graphics, confirms needle priming steps, and guides subcutaneous injection site rotation to prevent localized lipohypertrophy. Spatial adherence tools replace passive smartphone alarms with context-aware, domestic reminders tied to Bluetooth beacons and daily behavioral routines. Computer vision algorithms identify dispersed oral tablets on sorting tables, visually separating morning doses from evening regimens to prevent accidental polypharmacy duplications. Generative AI avatars act as personalized, empathetic health coaches, using motivational interviewing and affective computing to address treatment fatigue and encourage adherence. Rigorous randomized controlled trials demonstrate that AR-guided interventions yield statistically significant elevations in the Proportion of Days Covered, reduce critical device handling errors by over seventy percent, improve objective clinical endpoints (such as HbA1c and FEV₁), and deliver favorable Incremental Cost-Effectiveness Ratios that support formal digital therapeutic reimbursement.
Keywords: Adherence, Inhalers, Autoinjectors, Micro-nudges, Biometrics, Formulations
. 